Technological advances in the design and delivery of mRNA have catalysed the rapid development of mRNA COVID-19 vaccines by ...

The biotechnology company’s messenger RNA flu vaccine candidate showed positive results in a late-stage trial.

Thus, a short ∼ 12-bp RNA duplex formed by sRNA binding far inside the ompD CDS is necessary and sufficient to promote rapid mRNA decay. This mechanism requires both Hfq and RNase E.

The growing incidence of infectious diseases, cancer, and chronic illnesses has substantially increased the demand for ...

Chronic heart failure and hypoalbuminaemia are linked to a poor antibody response at 3 months after the third dose of the ...

The promise of mRNA technology seemed boundless after the success of the coronavirus vaccines, but Robert F. Kennedy Jr. has singled it out for scrutiny, clouding its prospects.

President Trump’s administration has slammed the brakes on development of messenger RNA (mRNA) vaccines, which proved their lifesaving potential during the COVID-19 pandemic but have come und… ...

Moderna this week announced positive data from a phase 3 trial of its messenger RNA vaccine against seasonal influenza, which ...

Discover how mRNA vaccines could revolutionize medicine by targeting 9 major diseases. Learn about breakthrough treatments ...

The mRNA metabolism passively shapes the levels of an mRNA modification called m6A within a steady-state cell and upon stress.